Biohaven Ltd (BHVN)
48.66
-0.38
(-0.77%)
USD |
NYSE |
Nov 14, 16:00
48.66
0.00 (0.00%)
After-Hours: 17:58
Biohaven Total Liabilities (Quarterly): 198.90M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 198.90M |
| March 31, 2024 | 117.08M |
| December 31, 2023 | 85.24M |
| September 30, 2023 | 92.73M |
| June 30, 2023 | 119.48M |
| Date | Value |
|---|---|
| March 31, 2023 | 146.26M |
| December 31, 2022 | 123.01M |
| September 30, 2022 | 35.43M |
| June 30, 2022 | 70.58M |
| December 31, 2021 | 47.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.43M
Minimum
Sep 2022
198.90M
Maximum
Jun 2024
103.61M
Average
104.91M
Median
Total Liabilities (Quarterly) Benchmarks
| Scholar Rock Holding Corp | 93.24M |
| Veru Inc | 27.01M |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Vanda Pharmaceuticals Inc | 108.86M |
| Oramed Pharmaceuticals Inc | 8.069M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 582.64M |
| Shareholders Equity (Quarterly) | 383.74M |